Dr. Kevin J. Cullen

Dr. Kevin J. Cullen, MD, is a nationally recognized medical oncologist specializing in head and neck cancers. He serves as Professor of Medicine and Director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, where he has been a driving force in cancer research and clinical care innovation. Dr. Cullen earned his medical degree from the University of Pennsylvania School of Medicine, followed by residency training in internal medicine and fellowship training in medical oncology at Beth Israel Hospital and Harvard Medical School. He is board-certified in Internal Medicine and Medical Oncology and is widely regarded for his leadership in advancing translational research and community-focused cancer care.

Dr. Cullen’s research has focused on the biology and treatment of head and neck cancers, particularly investigating molecular pathways of resistance and the integration of novel therapies into standard care. He has led clinical trials evaluating targeted therapies and immunotherapies, contributing to the development of precision oncology strategies in this disease area. In addition to his scientific work, Dr. Cullen has been a leading voice in national cancer policy, serving as chair of the FDA Oncology Drugs Advisory Committee and as a member of the National Cancer Institute’s Board of Scientific Advisors.

Committed to equity in cancer care, Dr. Cullen has championed programs that address disparities in cancer outcomes, particularly in underserved communities. As a mentor and educator, he has trained numerous medical oncologists and researchers who now carry forward his commitment to clinical excellence and patient advocacy. Through his leadership in clinical innovation, policy, and mentorship, Dr. Kevin J. Cullen continues to shape the future of oncology both within Maryland and across the nation.